{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:35:35Z","timestamp":1784694935353,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["16\/31\/63"],"award-info":[{"award-number":["16\/31\/63"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.conctc.2023.101124","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T20:28:24Z","timestamp":1679689704000},"page":"101124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["COVID-19 and the Physio4FMD trial: Impact, mitigating strategies and analysis plans"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9973-1131","authenticated-orcid":false,"given":"Louise","family":"Marston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9479-8599","authenticated-orcid":false,"given":"Marie","family":"Le Novere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2146-9628","authenticated-orcid":false,"given":"Irwin","family":"Nazareth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7425-0964","authenticated-orcid":false,"given":"Alan","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-9015","authenticated-orcid":false,"given":"Mark","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9387-3035","authenticated-orcid":false,"given":"Laura H.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2037-4902","authenticated-orcid":false,"given":"Jonathan","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-1609","authenticated-orcid":false,"given":"Hayley","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-6705","authenticated-orcid":false,"given":"Markus","family":"Reuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9829-8092","authenticated-orcid":false,"given":"Jon","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-8934","authenticated-orcid":false,"given":"Rachael M.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6053-5670","authenticated-orcid":false,"given":"Glenn","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2023.101124_bib1","series-title":"Functional Neurologic Disorders, Vol 139 of the Handbook of Clinical Neurology Series","first-page":"47","article-title":"Epidemiology","author":"Carson","year":"2016"},{"key":"10.1016\/j.conctc.2023.101124_bib2","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2018.1264","article-title":"Current concepts in diagnosis and treatment of functional neurological disorders","volume":"75","author":"Espay","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.conctc.2023.101124_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2340\/16501977-1246","article-title":"Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up","volume":"46","author":"Jordbru","year":"2014","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/j.conctc.2023.101124_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/jnnp-2016-314408","article-title":"Randomised feasibility study of physiotherapy for patients with functional motor symptoms","volume":"88","author":"Nielsen","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.conctc.2023.101124_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-019-1461-9","article-title":"Physio4FMD: protocol for a multicentre randomised controlled trial of specialist physiotherapy for functional motor disorder","volume":"19","author":"Nielsen","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.conctc.2023.101124_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-04711-6","article-title":"It is unprecedented: trial management during the COVID-19 pandemic and beyond","volume":"21","author":"Mitchell","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.conctc.2023.101124_bib7","doi-asserted-by":"crossref","first-page":"m1172","DOI":"10.1136\/bmj.m1172","article-title":"Clinical trials suspended in UK to prioritise covid-19 studies and free up staff","volume":"368","author":"Thornton","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.conctc.2023.101124_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(20)31787-6","article-title":"COVID-19 and readjusting clinical trials","volume":"396","author":"van Dorn","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.conctc.2023.101124_bib9","series-title":"Guidance on Minimising Disruptions to the Conduct and Integrity of Clinical Trials of Medicines during COVID-19","year":"2020"},{"key":"10.1016\/j.conctc.2023.101124_bib10","series-title":"Points to Consider on Implications of Coronavirus Disease (COVID-19) on Methodological Aspects of Ongoing Clinical Trials","year":"2020"},{"key":"10.1016\/j.conctc.2023.101124_bib11","series-title":"Conduct of Clinical Trials of Medical Products during the COVID-19 Public Health Emergency Guidance for Industry, Investigators, and Institutional Review Boards for Questions on Clinical Trial Conduct during the COVID-19 Pandemic, Please Email Clinicaltri","year":"2020"},{"key":"10.1016\/j.conctc.2023.101124_bib12","series-title":"E9 (R1) Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials - Step 2b","year":"2017"},{"key":"10.1016\/j.conctc.2023.101124_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-020-01089-6","article-title":"A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic","volume":"20","author":"Cro","year":"2020","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.conctc.2023.101124_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12603-009-0010-4","article-title":"The SF-36: a simple, effective measure of mobility-disability for epidemiological studies","volume":"13","author":"Syddall","year":"2009","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.conctc.2023.101124_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/01241398-200409000-00011","article-title":"The functional mobility scale (FMS)","volume":"24","author":"Graham","year":"2004","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.conctc.2023.101124_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870440290001494","article-title":"The revised illness perception questionnaire (IPQ-R)","volume":"16","author":"Moss-Morris","year":"2002","journal-title":"Psychol. Health"},{"key":"10.1016\/j.conctc.2023.101124_bib17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1212\/WNL.0b013e318228c0c7","article-title":"Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial","volume":"77","author":"Sharpe","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.conctc.2023.101124_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.conctc.2023.101124_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12883-015-0350-0","article-title":"COgnitive behavioural therapy vs standardised medical care for adults with Dissociative non-Epileptic Seizures (CODES): a multicentre randomised controlled trial protocol","volume":"15","author":"Goldstein","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.conctc.2023.101124_bib20","author":"Beecham"},{"key":"10.1016\/j.conctc.2023.101124_bib21","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.conctc.2023.101124_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","article-title":"The estimation of a preference-based measure of health from the SF-36","volume":"21","author":"Brazier","year":"2002","journal-title":"J. Health Econ."},{"key":"10.1016\/j.conctc.2023.101124_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/JOM.0b013e3182029110","article-title":"Productivity and health: an application of three perspectives to measuring productivity","volume":"53","author":"Lenneman","year":"2011","journal-title":"J. Occup. Environ. Med.\/American College of Occupational and Environmental Medicine"},{"key":"10.1016\/j.conctc.2023.101124_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med."},{"key":"10.1016\/j.conctc.2023.101124_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1191\/1740774505cn076oa","article-title":"Design and analysis of clinical trials with clustering effects due to treatment","volume":"2","author":"Roberts","year":"2005","journal-title":"Clin. Trials"},{"key":"10.1016\/j.conctc.2023.101124_bib26","series-title":"Hierarchical Linear Models: Applications and Data Analysis Methods","author":"Raudenbush","year":"2002"},{"key":"10.1016\/j.conctc.2023.101124_bib27","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2307\/1913827","article-title":"Specification tests in econometrics","volume":"46","author":"Hausman","year":"1978","journal-title":"Applied Econometrics"},{"key":"10.1016\/j.conctc.2023.101124_bib28","author":"Rabe-Hesketh","year":"2022"},{"key":"10.1016\/j.conctc.2023.101124_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1037\/1082-989X.3.2.147","article-title":"Statistical techniques for analyzing data from prevention trials: treatment of No-shows using rubin's causal model","volume":"3","author":"Little","year":"1998","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.conctc.2023.101124_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jval.2020.10.002","article-title":"Content of health economics analysis plans (HEAPs) for trial-based economic evaluations: expert delphi consensus Survey","volume":"24","author":"Thorn","year":"2021","journal-title":"Value Health"},{"key":"10.1016\/j.conctc.2023.101124_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ."},{"key":"10.1016\/j.conctc.2023.101124_bib32","series-title":"Unit Costs of Health and Social Care","author":"Curtis","year":"2020"},{"key":"10.1016\/j.conctc.2023.101124_bib33","series-title":"National Cost Collection for the NHS","year":"2020"},{"key":"10.1016\/j.conctc.2023.101124_bib34","series-title":"British National Formulary (Online) London","year":"2020"},{"key":"10.1016\/j.conctc.2023.101124_bib35","series-title":"Annual Survey of Hours and Earnings (ASHE) - Office for National Statistics","year":"2020"},{"key":"10.1016\/j.conctc.2023.101124_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40273-014-0247-6","article-title":"An educational review of the statistical issues in analysing utility data for cost-utility analysis","volume":"33","author":"Hunter","year":"2015","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.conctc.2023.101124_bib37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","article-title":"Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets","volume":"15","author":"Van Hout","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.conctc.2023.101124_bib38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hec.635","article-title":"Representing uncertainty: the role of cost-effectiveness acceptability curves","volume":"10","author":"Fenwick","year":"2001","journal-title":"Health Econ."},{"key":"10.1016\/j.conctc.2023.101124_bib39","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1007\/s11136-021-02833-1","article-title":"Psychometric assessment of EQ-5D-5L and ReQoL measures in patients with anxiety and depression: construct validity and responsiveness","volume":"30","author":"Franklin","year":"2021","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.conctc.2023.101124_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: a review","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.conctc.2023.101124_bib41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/19466315.2020.1779122","article-title":"Statistical issues and recommendations for clinical trials conducted during the COVID-19 pandemic","volume":"12","author":"Daniel Meyer","year":"2020","journal-title":"Stat. Biopharm. Res."},{"key":"10.1016\/j.conctc.2023.101124_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/1475-5890.12227","article-title":"The wider impacts of the coronavirus pandemic on the NHS","volume":"41","author":"Propper","year":"2020","journal-title":"Fisc. Stud."},{"key":"10.1016\/j.conctc.2023.101124_bib43","article-title":"Health-related quality of life and mental well-being of healthy and diseased persons in 8 countries: does stringency of government response against early COVID-19 matter?","volume":"15","author":"Long","year":"2021","journal-title":"SSM Popul Health"},{"key":"10.1016\/j.conctc.2023.101124_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.puhe.2021.12.016","article-title":"Tiered restrictions for COVID-19 in England: knowledge, motivation and self-reported behaviour","volume":"204","author":"Smith","year":"2022","journal-title":"Publ. Health"},{"key":"10.1016\/j.conctc.2023.101124_bib45","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2020.79","article-title":"Impact of the COVID-19 pandemic and initial period of lockdown on the mental health and well-being of adults in the UK","volume":"6","author":"White","year":"2020","journal-title":"BJPsych Open"}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865423000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865423000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:12:58Z","timestamp":1762521178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865423000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":45,"alternative-id":["S2451865423000704"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2023.101124","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and the Physio4FMD trial: Impact, mitigating strategies and analysis plans","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2023.101124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101124"}}